Commodore Capital LP Arca Biopharma, Inc. Transaction History
Commodore Capital LP
- $1.12 Billion
- Q2 2024
A detailed history of Commodore Capital LP transactions in Arca Biopharma, Inc. stock. As of the latest transaction made, Commodore Capital LP holds 414,325 shares of ABIO stock, worth $0. This represents 0.14% of its overall portfolio holdings.
Number of Shares
414,325Holding current value
$0% of portfolio
0.14%Shares
1 transactions
Others Institutions Holding ABIO
# of Institutions
34Shares Held
12.9MCall Options Held
41.6KPut Options Held
5.6K-
Cable Car Capital LLC San Francisco, CA4MShares$016.14% of portfolio
-
Rtw Investments, LP New York, NY1.4MShares$00.09% of portfolio
-
Janus Henderson Group PLC London, X01.38MShares$00.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA1.2MShares$00.01% of portfolio
-
Avidity Partners Management LP Dallas, TX1MShares$00.19% of portfolio
About ARCA biopharma, Inc.
- Ticker ABIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,410,100
- Description
- ARCA biopharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes genetically targeted therapies for cardiovascular diseases. Its lead product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), which is in Phase IIb clinical trial for the treatment for COVID-19; and Gencaro (bucindolol hydr...